Socialiya - Entertainment. Knowledge. Community.
FDA Approves Merck’s Once-Daily IDVYNSO™ (doravirine/islatravir)

IDVYNSO is approved for adults with virologically suppressed HIV-1 with no history of virologic trea...

BUSINESS NEWS April 21, 2026

FDA Approves Merck’s Once-Daily IDVYNSO™ (doravirine/islatravir)

IDVYNSO is approved for adults with virologically suppressed HIV-1 with no history of virologic treatment failure and no known substitutions associated with...

10 views 0 likes 0 comments
Share:
IDVYNSO is approved for adults with virologically suppressed HIV-1 with no history of virologic treatment failure and no known substitutions associated with...

Author: Merck.com

Read Original Article

Related News

Advertisement
APNA POS
Advertisement
socialiya
Advertisement

Top Categories

Advertisement
socialiya
Advertisement
APNA POS
Advertisement
socialiya
Advertisement
socialiya